Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
18.01.2024 09:01AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): BUY
BUY
MAX lays the foundation for outperformance in 2024
Topic: MAX Automation has another promising year in front of it. We expect
the company to grow its topline by 7% in 2024e while sustaining last year’s
profitability (eNuW).
Topline growth ahead: With several structural trends kicking in, MAX should
be able to grow its revenue in the cur [ … ]
16.01.2024 10:02AM
Study issued by GBC AG
Cenit AG (von GBC AG): BUY
BUY
First acquisition of 2024 strengthens the 3DS Solutions division; forecasts
and target price unchanged
As expected, CENIT AG is continuing the high level of acquisition activity
implemented since the 2022 financial year in the 2024 financial year. As
the company announced in the second calendar week of the still young year,
CCE b:digital G [ … ]
16.01.2024 09:01AM
Study issued by NuWays AG
DEMIRE AG (von NuWays AG): HOLD
HOLD
LogPark finally sold + letting success to start crucial 2024
After the disposal of the LogPark in Leipzig to CommerzReal initially fell
through in July 2023, DEMIRE has now found a new buyer, namely HIH Invest
Real Estate. We estimate the purchase price, which was not disclosed, to be
in the range of € 100-105m, hence being some 15% below [ … ]
15.01.2024 09:11AM
Study issued by NuWays AG
bet-at-home.com AG (von NuWays AG): HOLD
HOLD
Outlook for 2024: A promising bet
After two transition years that were characterized by risks associated with
the liquidation of the Entertainment Ldt. as well as customer claims in
Austria and Germany on the one hand and restructuring and stabilizing the
remaining business on the other hand, we see good chances that we have seen
the trough in [ … ]
12.01.2024 09:02AM
Study issued by NuWays AG
USU Software AG (von NuWays AG): BUY
BUY
Strong order intake to start transitionary 2024e
This week, USU announced to have won two public sector framework contracts
to start the year on a positive note: (1) Germany’s Federal Employment
Agency (BA) commissioned USU for its TEBIT (Technical Inventory Management
System IT) project. The TEBIT system of the BA is based on the USU
Val [ … ]
09.01.2024 09:01AM
Study issued by NuWays AG
Rubean AG (von NuWays AG): BUY
BUY
FY23 sales in line with estimates // POS rollout has started; chg
Topic: Yesterday, Rubean announced to have reached more than € 1.0m in
sales (prelims) and quadrupled number of app users to c. 25k vs 6k at the
end of 2022 (eNuW).
With > € 1.0m, Rubean increased sales by >20% yoy, which is slightly better
than expected (eNuW o [ … ]
05.01.2024 09:01AM
Study issued by NuWays AG
ZEAL Network SE (von NuWays AG): BUY
BUY
Online transformation with ongoing momentum
Topic: Yesterday, the state lottery operator DLTB released its 2023 lottery
data, revealing a continuous and strong outperformance of the online
distribution channel.
Online transformation in full swing: In total, lottery players played for
c. € 2bn via online channels, marking a solid 10.4% grow [ … ]
20.12.2023 12:07PM
Study issued by First Berlin Equity Research GmbH
M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 11,90 auf EUR 13,20.
Zusammenfassung:
Im November stärkte M1 seine Botox-Lieferkette durch den Erwerb der Nutri
Care GmbH und ihrer hu [ … ]
18.12.2023 09:02AM
Study issued by NuWays AG
Rubean AG (von NuWays AG): BUY
BUY
PhonePOS rollout is starting right now; chg
Topic: After Rubean 1) solved its liquidity issues, 2) finally published
its FY22 figures that were in line with expectations and 3) announced
several promising partnerships, we are more optimistic that the rollout of
POS is starting right now and should have the potential to ramp-up sales.
Liquidit [ … ]
15.12.2023 09:31AM
Study issued by GBC AG
HAEMATO AG (von GBC AG): suspended
suspended
Delisting of the HAEMATO share to take place from February 2023; price
potential not yet exhausted; GBC-rating and GBC-price target suspended
HAEMATO has announced the termination of the inclusion of the shares in the
open market of 30 November 2023. The shares are to be delisted after expiry
of the notice period, at the latest by the end [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL